Literature DB >> 9135283

Children conceived by in vitro fertilisation after fresh embryo transfer.

S W D'Souza1, E Rivlin, J Cadman, B Richards, P Buck, B A Lieberman.   

Abstract

AIMS: To compare the outcome in in vitro fertilisation (IVF) children (after fresh embryo transfer) from multiple and singleton births with one another, and with normally conceived control children.
METHODS: A cohort of 278 children (150 singletons, 100 twins, 24 triplets and four quadruplets), conceived by IVF after three fresh embryos had been transferred, born between October 1984 and December 1991, and 278 normally conceived control children (all singletons), were followed up for four years after birth. They were assessed for neonatal conditions, minor congenital anomalies, major congenital malformations, cerebral palsy and other disabilities. Control children, all born at term, were matched for age, sex and social class.
RESULTS: The ratio of male:female births was 1.03. Forty six per cent of IVF children were from multiple births; 34.9% were from preterm deliveries; and 43.2% weighed less than 2500 g at birth. The IVF singletons were on average born one week earlier than the controls, weighed 400 g less, and had a threefold greater chance of being born by caesarean section. The higher percentage of preterm deliveries was largely due to multiple births and they contributed to neonatal conditions in 45.0% of all IVF children. The types of congenital abnormalities varied: 3.6% of IVF children and 2.5% of controls had minor congenital anomalies, and 2.5% of IVF children and none of the controls had major congenital malformations. The numbers of each specific type of congenital abnormality were small and were not significantly related to multiple births. IVF children (2.1%) and 0.4% of the controls had mild/moderate disabilities. They were all from multiple births, including two children with cerebral palsy who were triplets.
CONCLUSIONS: The outcome of IVF treatment leading to multiple births is less satisfactory than that in singletons because of neonatal conditions associated with preterm delivery and disabilities in later childhood. A reduction of multiple pregnancies by limiting the transfer of embryos to two instead of three remains a high priority.

Entities:  

Mesh:

Year:  1997        PMID: 9135283      PMCID: PMC1720629          DOI: 10.1136/fn.76.2.f70

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  28 in total

1.  Classification, nomenclature, and naming of morphologic defects.

Authors:  W D Smith
Journal:  J Pediatr       Date:  1975-07       Impact factor: 4.406

2.  Selective reduction of multifetal pregnancies in the first trimester.

Authors:  R L Berkowitz; L Lynch; U Chitkara; I A Wilkins; K E Mehalek; E Alvarez
Journal:  N Engl J Med       Date:  1988-04-21       Impact factor: 91.245

3.  Neurodevelopmental outcome in babies weighing less than 2001 g at birth.

Authors:  N Marlow; S W D'Souza; M L Chiswick
Journal:  Br Med J (Clin Res Ed)       Date:  1987-06-20

4.  Increasing prevalence of multiple confinements in Western Australia and the impact of in-vitro fertilization.

Authors:  S Webb; D Moore; F Stanley
Journal:  Med J Aust       Date:  1987-08-03       Impact factor: 7.738

5.  Recent trends in the incidence of multiple births and associated mortality.

Authors:  B J Botting; I M Davies; A J Macfarlane
Journal:  Arch Dis Child       Date:  1987-09       Impact factor: 3.791

6.  Congenital malformations after in-vitro fertilisation.

Authors:  P A Lancaster
Journal:  Lancet       Date:  1987-12-12       Impact factor: 79.321

7.  In vitro fertilization and embryo transfer in human beings.

Authors:  J D Biggers
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

8.  Minor congenital anomalies, major congenital malformations and development in children conceived from cryopreserved embryos.

Authors:  A G Sutcliffe; S W D'Souza; J Cadman; B Richards; I A McKinlay; B Lieberman
Journal:  Hum Reprod       Date:  1995-12       Impact factor: 6.918

9.  How does one assess the risk of abnormalities from human in vitro fertilization?

Authors:  J J Schlesselman
Journal:  Am J Obstet Gynecol       Date:  1979-09-01       Impact factor: 8.661

10.  An analysis of the obstetric outcome of 125 consecutive pregnancies conceived in vitro and resulting in 100 deliveries.

Authors:  M C Andrews; S J Muasher; D L Levy; H W Jones; J E Garcia; Z Rosenwaks; G S Jones; A A Acosta
Journal:  Am J Obstet Gynecol       Date:  1986-04       Impact factor: 8.661

View more
  6 in total

Review 1.  Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies.

Authors:  Frans M Helmerhorst; Denise A M Perquin; Diane Donker; Marc J N C Keirse
Journal:  BMJ       Date:  2004-01-23

2.  Epigenetics and assisted reproductive technology: a call for investigation.

Authors:  Emily L Niemitz; Andrew P Feinberg
Journal:  Am J Hum Genet       Date:  2004-02-27       Impact factor: 11.025

3.  A meta-analysis of the impact of IVF and ICSI on major malformations after adjusting for the effect of subfertility.

Authors:  Alfred A Rimm; Alyce C Katayama; K Paul Katayama
Journal:  J Assist Reprod Genet       Date:  2011-05-31       Impact factor: 3.412

4.  A meta-analysis of controlled studies comparing major malformation rates in IVF and ICSI infants with naturally conceived children.

Authors:  Alfred A Rimm; Alyce C Katayama; Mireya Diaz; K Paul Katayama
Journal:  J Assist Reprod Genet       Date:  2004-12       Impact factor: 3.412

5.  Profile of Live-born Infants of In-vitro Fertilisation.

Authors:  S Narayan; K S Rana; M Sharma; R K Sharma; P Talwar; K Kapur; B K Goyal
Journal:  Med J Armed Forces India       Date:  2011-07-21

6.  Caesarean section in pregnancies conceived by assisted reproductive technology: a systematic review and meta-analysis.

Authors:  Nakeisha A Lodge-Tulloch; Flavia T S Elias; Jessica Pudwell; Laura Gaudet; Mark Walker; Graeme N Smith; Maria P Velez
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-22       Impact factor: 3.007

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.